BDC-4182
BBI-4182-101
Phase 2 small_molecule active
Quick answer
BDC-4182 for Gastric Cancer Adenocarcinoma Metastatic is a Phase 2 program (small_molecule) at Bolt Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bolt Biotherapeutics
- Indication
- Gastric Cancer Adenocarcinoma Metastatic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active